Klotho therapeutics inc
WebKlotho Therapeutics, Inc., (KTI) is a privately held biotechnology company developing modified recombinant versions of the human protein Klotho that has shown great … WebApr 29, 2024 · The antiaging, life-extending, and cognition-enhancing protein Klotho is neuroprotective due to its anti-inflammatory, antioxidative, and pro-myelinating effects. In addition, Klotho is also a tumor suppressor and has beneficial roles in multiple organs. Klotho is downregulated as part of the aging process.
Klotho therapeutics inc
Did you know?
WebMar 1, 2024 · KLOTHO is a type of β-glucuronidase engaged in the development and progression of reproductive diseases with anti-aging and antioxidant properties . Decreased KLOTHO expression was found in women with DOR , and overexpression of KLOTHO was related to higher blastocyst formation frequency in porcine cell lines . Our bioinformatics … WebKlotho is an anti-aging transmembrane protein, which can be shed and can function as a hormone. Accumulating data indicate that klotho is a tumor suppressor in a wide array of malignancies, and designate the subdomain KL1 as the active region of the protein towards this activity. ... Klogenix Therapeutics Inc., Boston, MA 02116, USA. 8 ...
WebKLOTHO Therapeutics (KTI ™) is a biotechnology company developing a patent-pending Klotho protein that has great potential to redefine society’s experience with aging. KTI has … KLOTHO Therapeutics (KTI™) is a biotechnology company developing a … Your Contact Information. Name*. Phone Number*. Email Address*. Klotho is an anti-aging hormone detected in the brain, kidneys, urine, blood stream, … Klotho suppresses tumor growth, inhibits metastases, reduces resistance to … Klotho is a single-pass transmembrane protein that is highly expressed in the … SAN DIEGO, Nov. 2, 2024 / PRNewswire / — Klotho Therapeutics, Inc. (KTI), a … Interested In Joining Our Team? Please send your CV to: [email protected] WebJun 3, 2024 · The principals have now branched out into the development of therapies based on increasing circulating levels of klotho, a protein found to affect, at the very least, both kidney function and cognitive function. It was discovered some time ago in mice that raised levels of klotho modestly slow aging, while lowered levels accelerate aging.
WebKlotho Therapeutics Employee Directory . Klotho Therapeutics corporate office is located in 850 New Burton Rd Ste 201, Dover, Delaware, 19904, United States and has 10 employees. WebOwner: Klotho Therapeutics, Inc. Docket/Reference No. 20780.21: Issue Date: March 25, 2024: Your mark is scheduled to publish in the Trademark Official Gazette (TMOG) on April 14, 2024. Your mark appears to be entitled to register on the Principal Register upon the acceptance of a statement of use, subject to any claims of concurrent use.
WebNov 3, 2024 · Klotho Therapeutics, Inc. (KTI), a San Diego, CA-based biotechnology company focused on commercializing its patent pending version of the protein/hormone Klotho, held the first closing of a...
WebJun 27, 2024 · About Klogene Therapeutics, Inc. Klogene is developing therapies based on increasing the level of Klotho protein. Media Contact: 1-781-718-5102 [email protected] … powerapps align centerWebDec 20, 2024 · The α-Klotho protein is a circulating factor associated with improved cognitive performance in preclinical studies. α-Klotho is hypothesized to optimize … powerapps alert boxWebJun 27, 2024 · Klotho is a naturally occurring, anti-aging pleiotropic human protein/hormone that has been shown to have potential therapeutic effects in neurodegenerative diseases, kidney disease, certain... powerapps alertWebNov 2, 2024 · Klotho Therapeutics (KTI) is a biotechnology company developing a patent-pending Klotho protein that has great potential to delay diseases of aging and help people live well longer. Naturally occurring in humans and animals, Klotho positively influences longevity, cognition and kidney function as well as slowing progression of diabetes and … powerapps all functionsWebNov 2, 2024 · The company has developed a modified recombinant version of the human protein Klotho that has the potential to delay diseases of aging and improve longevity, … power app salesforceWebCo-Founder at Klotho ex-Microsoft ex-Riot 2mo #InfrastructureFromCode (or #IfC) is growing and shifting the focus from infrastructure-centric cloud development models to application-centric... powerapps alert popupWebNov 3, 2024 · Klotho Therapeutics has raised a total of $10M in funding over 1 round. This was a Series A round raised on Nov 3, 2024. Klotho Therapeutics is funded by Thynk Capital, LLC.. Klotho Therapeutics has a post-money valuation in the range of $10M to $50M as of Nov 3, 2024, according to PrivCo. powerapp salesforce mulesoft